Animal Allergies

Food Allergies

Allergy, Immunology, and ENT

Cardiovascular Diseases

Cardiology

Acne

Atopic Dermatitis

Dermatology

Emergency Medicine

Diabetes

Endocrinology

Formula

Nutrition

Obesity

Gastroenterology

Antibiotic Resistance

Bacterial Conjunctivitis

COVID-19

Influenza

Pneumonia

Sexually Transmitted Diseases

Vaccination and Immunization

Vaccines

Infectious Diseases

ADHD

Addiction

Antisocial Personality Disorder

Anxiety

Autism

Depression

Developmental/Behavioral Disorders

Psychiatry

Mental, Behavioral and Development Health

Concussion

Epilepsy

Headache

Neurology

Neonatal/Perinatology

OB/GYN

Pain

Drug Pipeline News

Pharmacology

Telemedicine

Practice Improvement

Asthma

Cystic Fibrosis

Respiratory

Rheumatology

News 

All News

PNP Corner

AAP News

Media

Around the Practice

Cure Connections

Expert Interviews

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Podcasts

Webinars

Puzzler

Publications

Contemporary Pediatrics Journal

Supplements And Featured Publications

CME/CE

Resources

Handouts

Job Board

Conferences

Conference Coverage

Conference Listing

Partnerships

Subscribe

Editorial

Editorial Advisory Board

Writer’s Guidelines

Reference Guidelines

Meet the Editors

Michael O. Daines, MD, division chief, Pediatric Allergy and Immunology, University of Arizona College of Medicine; Principal investigator, phase 3 study of Panzyga for PANS. 

Articles

. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown State University in Youngstown, Ohio in 2020 with a degree in telecommunications and journalism. He started his career as a news and sports videographer before becoming an on-air sports anchor at the NBC-affiliated news station in Youngstown. Fitch briefly worked as a national content writer for a Chicago-based national television station before joining the 

team. He can be reached at: jfitch@mjhlifesciences.com.

In this video interview, Michael Daines, MD, explains phase 3 data for Panzyga (Octapharma) for pediatric acute- onset neuropsychiatric syndrome (PANS).

Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD

John Browning, MD, Chief of Dermatology at Children’s Hospital of San Antonio and Organon Health Partner.

Dr. John Browning Headshot (1).jpg

John Browning, MD, highlights why pediatricians should feel comfortable prescribing recent non-steroidals, and what questions to ask patients in office. 

John Browning, MD, explains dermatological questions to ask, answer in primary care

SheandaThambyrajah, MD, Resident, Loyola University

The patient described the headache as “pressure-like,” episodes that occurred for 1 to 2 hours with high severity.

A headache with a red flag in a 10-year-old girl

 and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining 

 You can reach her at mpetronelli@mjhlifesciences.com.

Lenacapavir is the first twice-yearly option available in the US for those who need or want PrEP, according to Gilead Sciences. 

FDA approves twice-yearly lenacapavir as PrEP for HIV in adolescents, adults 

Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Contemporary Pediatrics – Clinical News & Pediatrician Practice Tips

Facebook

LinkedIn

Instagram

Clinical

Gynecology

Infectious disease

Mental Health

Oncology

Rheumatoid Arthritis

Sexual Health

View More

1rem

An expert pediatrician discusses influenza vaccination for the pediatric population. He provides an overview of recommendations and different formulations of vaccines, as well as addresses vaccine hesitancy among guardians.

Seasonal Flu Vaccines in Pediatrics: An Expert Overview in Advancing Vaccine Technology

Gary Marshall, MD, provides expert guidance on vaccine technology for pediatric patients with influenza. 

Calling the Shots on Pediatric Flu:  Expert Guidance on Vaccine Technology 

An expert in infectious diseases among children discusses the burden of influenza among pediatric populations, the different types of flu vaccines, and the common challenges faced when getting the flu vaccine to children.

Expert Guidance on Pediatric Flu Vaccines: Selecting the Right Approach and Improving Uptake

Expert dermatologists highlight a patient case and discuss the importance of collaborative and multidisciplinary care in pediatric patients suffering from atopic dermatitis.

Collaborative Management in Pediatric Atopic Dermatitis

Experts in psychiatry discuss updates in the management of pediatric ADHD, highlighting a recent therapeutic approval and the clinical practice implications.

Updates in the Management of Pediatric ADHD

Elaine M. Apperson, MD, provides key insights on the screening, diagnosis, and management of type 1 diabetes in patients.

Optimizing Screening and Diagnosis of Type 1 Diabetes

An expert in diabetes care and education discusses considerations in the management of hypoglycemia and diabetes in school aged children.

Considerations for the Management of Hypoglycemia and Diabetes in Schools